Supernus Pharmaceuticals (SUPN) Q3 2026 Earnings

11AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
0.3
0.53
0.77
1.01

Details

Expected EPS
0.4375
Actual EPS
N/A
Surprise EPS
-0.44
Surprise Percent
+100%

Description

Supernus Pharmaceuticals (SUPN) will report earnings of for Q3 2026 on August 11, 2026.

0 Comments

Share your thoughts